In a move to expand the availability of essential medicines across Nigeria, Getz Pharma Nigeria Limited has partnered with CHI Pharmaceuticals Limited, a member of Tropical General Investments (TGI) Group, to leverage its nationwide distribution network, marking a major step toward improving access to quality healthcare across the country.
The partnership, which was announced during a strategy session at Lagos headquarters of CHI Pharma, gives Getz Pharma access to over 5,000 registered pharmaceutical outlets already covered by CHI Pharma, a network that reaches more than half of Nigeria’s licensed pharmacies.
Chief Operating Officer at CHI Pharma, Shriram Iyer said: ‘This is not just another handshake. Getz Pharma chose us for a reason. We have built deep relationships across Nigeria’s pharmaceutical landscape for almost three decades, and now, they are tapping into that infrastructure to bring lifesaving medications closer to the people who need them most’.
General Manager (Commercial) at Getz Pharma Nigeria, Syed Khairat Haider said: ‘Patients suffer when quality drugs are unavailable. This model ensures pharmacies and hospitals always have access. We are investing in sustainability, scale, and speed’.
The collaboration, formalised after six months of due diligence, is built on a multiple distribution model that ensures product availability and business continuity.
With a combined field force of over 60 people focused on activation, awareness, and distribution, the partnership allows each company to focus on their core strengths: Getz Pharma will drive physician engagement and education, while CHI Pharma manages last-mile delivery and retail placement.
Sales Director for General Trade at CHI Pharma, Timothy Olabiyi explained: ‘We have built this model to ensure deep penetration of Getz Pharma brands into pharma channels such as wholesale pharmacies, retail pharmacies and. We have done this successfully with over 17 other partners, and each time, the focus is the same: access, affordability, and ethical distribution’.
While CHI Pharma’s proprietary brands like Supramult® and Co-Mal® continue under a separate umbrella, the Getz partnership like other distribution partnerships will be carried out by our field force sole focused on product placement and visibility within pharma channels.
‘Within the first few days of activation/ launch, we have already surpassed our initial sales targets. This is just the beginning. We are looking to expand into biologics and innovative therapies to raise the standard of care in Nigeria’, Haider said.
This new alliance follows recent CHI Pharma collaborations with EVA Pharma and Neimeth International Pharmaceuticals, reinforcing the company’s role as a trusted distribution partner for global and local pharmaceutical players targeting Nigeria.
